Ceptaris Therapeutics' Acquisition

Ceptaris Therapeutics was acquired by Actelion on September 20, 2013.

Ceptaris Therapeutics, formerly Yaupon Therapeutics, is developing a gel formulation of mechlorethamine hydrochloride (mechlorethamine) for the treatment of early stage (stages I-IIA) mycosis fungoide…

Articles about Ceptaris Therapeutics' Acquisition: